SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
54.4 |
% |
2.4 |
10.47 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47084 |
461 |
SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
52.69 |
% |
6.13 |
26.74 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47089 |
461 |
SS-Chr 13BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
19 |
|
0.27 |
IU/g |
0.04 |
0.16 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47477 |
461 |
SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
|
6.79 |
ml/min/g |
0.39 |
1.6 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44730 |
461 |
SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
48.23 |
% |
5.55 |
17.55 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46073 |
461 |
SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
56.56 |
% |
3.07 |
12.66 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46078 |
461 |
SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
|
6.09 |
ml/min/g |
0.36 |
1.48 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46213 |
461 |
SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
4.8 |
ml/min/g |
0.52 |
1.63 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46208 |
461 |
SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
19 |
|
6.62 |
ml/min/g |
0.27 |
1.18 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44725 |
461 |
SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
10.15 |
ml/min/g |
0.64 |
2.02 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46877 |
461 |
SS-Chr 13BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
9 |
|
30.61 |
IU/g |
3.05 |
9.15 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48888 |
461 |
SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
21 |
|
12.34 |
ml/min/g |
0.35 |
1.63 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46660 |
461 |
SS-Chr 13BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
21 |
|
0.44 |
IU/g |
0.06 |
0.28 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47468 |
461 |
SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
19 |
|
11.92 |
ml/min/g |
0.53 |
2.32 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46665 |
461 |
SS-Chr 13BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
17 |
|
0.34 |
IU/g |
0.03 |
0.14 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47341 |
461 |
SS-Chr 13BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
10 |
|
0.39 |
IU/g |
0.06 |
0.19 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47332 |
461 |
SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
|
10.89 |
ml/min/g |
0.46 |
1.89 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46882 |
461 |